Innoplexus Big steps to combat the coronavirus
Posted: Wed Jan 29, 2025 3:31 am
The German company Innoplexus AG, also known as the “Google of the pharmaceutical industry”, is taking further steps to quickly combat the coronavirus.
1. Innoplexus will make its world-leading Ontosight® AI search platform available free of charge to all medical research institutions worldwide relevant to Covid-19/SARS-Cov-2 for an initial phase.
2. To provide global decision-makers and the public with accurate and comprehensive information on all relevant developments on Covid-19 worldwide, a dashboard will be made available on the Internet and will be continuously updated.
3. Together with leading international researchers and pharmaceutical companies, Innoplexus has used its AI resources to identify approaches for combination therapies and new molecules to combat the coronavirus.
The coronavirus (Covid-19) is affecting the global economy and threatens to lead to asia gambling data a severe recession, not only in Innoplexus' core markets of the EU, USA and India. In recent days, a drastic change in political measures and a global paradigm shift in dealing with the coronavirus can be observed.
Decision-makers in politics, medicine and business can only judge whether the measures are effective and the opportunities outweigh the risks on the basis of reliable information and analyses. To help solve the enormous and complex challenges, Innoplexus has taken three important steps:
1. Opening of Ontosight® Discover to research institutes and university hospitals researching Covid-19
On March 13, Innoplexus opened its Ontosight® Discover platform to research institutes and university hospitals. The resulting central information and research platform for Covid-19 is the largest digital knowledge reservoir in the field of pharmacy.
This will be made available to all corona researchers, along with the world's leading analysis tool; researchers from Germany, the USA and India have already started using it. This is a direct response from Innoplexus to the urgent call from numerous countries such as Australia, Brazil, Canada, Germany, India, Italy , Japan, New Zealand, Singapore, South Korea and Great Britain to make all relevant publications available to the research community as comprehensively as possible.
1. Innoplexus will make its world-leading Ontosight® AI search platform available free of charge to all medical research institutions worldwide relevant to Covid-19/SARS-Cov-2 for an initial phase.
2. To provide global decision-makers and the public with accurate and comprehensive information on all relevant developments on Covid-19 worldwide, a dashboard will be made available on the Internet and will be continuously updated.
3. Together with leading international researchers and pharmaceutical companies, Innoplexus has used its AI resources to identify approaches for combination therapies and new molecules to combat the coronavirus.
The coronavirus (Covid-19) is affecting the global economy and threatens to lead to asia gambling data a severe recession, not only in Innoplexus' core markets of the EU, USA and India. In recent days, a drastic change in political measures and a global paradigm shift in dealing with the coronavirus can be observed.
Decision-makers in politics, medicine and business can only judge whether the measures are effective and the opportunities outweigh the risks on the basis of reliable information and analyses. To help solve the enormous and complex challenges, Innoplexus has taken three important steps:
1. Opening of Ontosight® Discover to research institutes and university hospitals researching Covid-19
On March 13, Innoplexus opened its Ontosight® Discover platform to research institutes and university hospitals. The resulting central information and research platform for Covid-19 is the largest digital knowledge reservoir in the field of pharmacy.
This will be made available to all corona researchers, along with the world's leading analysis tool; researchers from Germany, the USA and India have already started using it. This is a direct response from Innoplexus to the urgent call from numerous countries such as Australia, Brazil, Canada, Germany, India, Italy , Japan, New Zealand, Singapore, South Korea and Great Britain to make all relevant publications available to the research community as comprehensively as possible.